Tranzyme announces completion of merger with Ocera Therapeutics

Ocera Therapeutics and Tranzyme announced that, following a special meeting of the shareholders of Tranzyme held on July 15, the Ocera and Tranzyme merger has closed. The combined company is named Ocera Therapeutics, Inc. and will trade beginning July 16 on the NASDAQ Global Market under the symbol "OCRX".

Advertisement